Skip to main content

Table 2 Estimated posterior odds ratios of patient characteristics associated with the intended adjuvant therapies, and relative weights between therapies (Continued)

From: Geographic variation in the intended choice of adjuvant treatments for women diagnosed with screen-detected breast cancer in Queensland

First screen diagnosed     
Yes 1508 0.81 [0.69, 0.96] 0.79 [0.66, 0.94] 0.72 [0.63, 0.82]
No 4788 1.00 1.00 1.00
Surgery     
Breast-conserving surgery 4255 1.00 1.00 1.00
Mastectomy 2009 0.03 [0.02, 0.03] 1.63 [1.40, 1.91] 0.86 [0.76, 0.98]
No surgery 15 0.15 [0.04, 0.44] 2.26 [0.76, 6.61] 0.86 [0.49, 1.44]
Unknown 17 0.18 [0.06, 0.47] 1.70 [0.64, 4.71] 1.10 [0.66, 1.89]
Relative weight of shared component     
Radiotherapy   1.00
Chemotherapy   0.57 [0.36, 0.84] 1.00
Hormonal therapy   0.90 [0.68, 1.17] 1.59 [1.09, 2.47] 1.00
PPC 0.9993
  1. aAbbreviations: CrI Credible interval, N Number of patients, TRACT Travel to cancer treatment, IRSAD Index of relative socio-economic advantage and disadvantage, PPC Posterior predictive check